Hyperpigmentation due to the overuse of amorolfine nail lacquer

Korean Journal of Medical Mycology

Volumn 7, Issue 4, 2002, Pages 224-226

  Kim, Beom Joon ^a   Kim, Yu Jin ^a   Ro, Byung In ^a  

^a Chung Ang University   (South Korea)

Author keywords

Amorolfine; Hyperpigmentation

Indexed keywords

AMOROLFINE; ANTIFUNGAL AGENT;

ARTICLE; CASE REPORT; DERMATOMYCOSIS; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HYPERPIGMENTATION; NAIL DISEASE; ONYCHOMYCOSIS; TOE; TREATMENT OUTCOME; TRICHOPHYTON RUBRUM;

TRICHOPHYTON RUBRUM;

EID: 0036937747     PISSN: 12264709     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Polak A. Kinetics of amorolfine in human nails. Mycoses 1993; 36: 101-103
2. Rigopoulos D, Katsambas A, Antoniou C, Christofidou E, Balaskas E, Stratigos J. Discoloration of the nail plate due to the misuse of amorolfine 5% nail lacquer. Acta Derm Venereol 1996; 76: 83-84
3. Polak A, Hartman PG. Preclinical data of amorolphine. In: Rippon S, Fromtling RA, eds. Cutaneous antifungal agents. New york: Marcel Dekker Inc., 1993; 13-26
4. Franz ST. Absorption of amorolphine through human nail. Dermatology 1992; 184: 18-20
5. Dykes PJ, Thomas R, Finlay AY. Determination of terbinafine in nail samples during systemic treatment for onychomycoses. Br J Dermatol 1990; 123 (4): 481-486
6. Cauwenbergh G. Skin kinetics of azole antifungal drugs. Curr Top Med Mycol 1992; 4: 88-136
7. Daniel. Pigmentation abnormalities. In Nails: RK Scher, CR Daniel, eds. Therapy, Diagnosis, Surgery. Philadelphia: Saunders, 1990: 1553
8. Jeanmougin M, Civatte J. Nail dyschromia. Int J Dermatol 1983; 22: 279
9. Tosti A, Barab R, Piraccini BM, Cameli N, Fanti PA. Nail matrix nevi. J Am Acad Dermatol 1996; 34: 765
10. Personal communication: Galderma (France) file of amorolfine nail lacquer (Loceryl®)